Page 81 - IMO-1-1

Innovative Medicines & Omics Smp43 peptide

that Smp43 selectively induces apoptosis in target cells negative regulator of autophagy. This inhibition leads to
(e.g., cancer cells or virally infected cells) without affecting the activation of ULK1, a crucial kinase for autophagy
healthy cells is crucial for minimizing side effects. 13 initiation. Smp43 promotes the conversion of LC3-I to
LC3-II, a critical step in the expansion and formation
2.4.2. Immune response of the autophagosome membrane. By interacting with
Smp43 holds the potential to enhance both innate and components of the phagophore (the early structure of
adaptive immune responses, making it a promising the autophagosome), Smp43 facilitates its nucleation
candidate for various therapeutic applications. The peptide and elongation. In addition, it enhances the fusion of
can improve the function of dendritic cells and macrophages, autophagosomes with lysosomes, which is critical for
which are essential for antigen presentation and the the degradation of autophagic cargo. The peptide may
initiation of immune responses. In addition, Smp43 may stimulate lysosomal enzymes, improving the efficiency
stimulate the production of pro-inflammatory cytokines, of autophagic degradation. In addition, Smp43 could
such as IL-1, IL-6, and TNF-α, as well as chemokines promote mitophagy, the selective autophagy of damaged
that attract and activate other immune cells to sites of mitochondria, helping maintain mitochondrial quality
infection or inflammation. By enhancing the activation and and function. It may also enhance the clearance of protein
proliferation of T cells, including helper T cells (Th1 and aggregates, reducing cellular stress and preventing the
Th2) and cytotoxic T lymphocytes (CTLs), and increasing accumulation of toxic proteins. 15,17
the cytotoxic activity of natural killer cells, Smp43 boosts the
body’s capacity to identify and eliminate pathogens, infected By promoting autophagy, Smp43 helps ensure protein
cells, and tumor cells. The peptide may also facilitate B cell quality control, prevents the buildup of misfolded or
differentiation and antibody production, strengthening damaged proteins, and maintains overall cellular health
humoral immunity. Furthermore, Smp43 can modulate the by removing damaged organelles. Enhanced autophagy
function of regulatory T cells, helping to maintain immune can provide an alternative energy source during nutrient
tolerance and prevent autoimmune responses. By balancing deprivation by recycling cellular components. By reducing
pro-inflammatory and anti-inflammatory cytokines, oxidative stress through the removal of damaged organelles
Smp43 may regulate inflammation, prevent excessive and proteins, Smp43 protects cells from damage. In cancer,
tissue damage, and offer therapeutic benefits in chronic autophagy can have dual effects; while Smp43 may prevent
inflammatory conditions such as rheumatoid arthritis and cancer initiation by eliminating damaged cells, excessive
inflammatory bowel disease. Its ability to counteract tumor autophagy could support the survival of cancer cells
immune evasion and enhance immune responses positions under stress. Smp43-induced autophagy may be beneficial
Smp43 as a potential adjunct in cancer immunotherapy and in the treatment of neurodegenerative diseases, such as
as an adjuvant in vaccines, improving their effectiveness. 14,16 Alzheimer’s and Parkinson’s by eliminating toxic protein
aggregates. Furthermore, enhanced autophagy could
Previous studies using cultured immune cells have improve immune defense mechanisms by promoting
provided in-depth insights into how Smp43 affects various cell the clearance of intracellular pathogens and modulating
types, including T cells, B cells, macrophages, and dendritic antigen presentation and immune cell function. 14,18
cells, and have identified the molecular pathways involved
in its immune modulation. Measuring cytokine production Previous studies using various cell lines are vital for
in response to Smp43 treatment has helped reveal its impact elucidating how Smp43 induces autophagy, including its
on immune signaling networks. Research in animal models effects on gene expression, autophagosome formation,
is crucial for assessing the systemic effects of Smp43 on and lysosomal activity. Research into its impact on key
immune responses and determining its efficacy in combating autophagy-related pathways, such as mTOR, AMPK, and
infections and tumors. By evaluating its performance in PI3K/Akt, will help clarify its role in autophagy regulation.
models of infectious diseases, cancer, and autoimmune Animal model studies are essential for understanding
conditions, researchers can explore the therapeutic potential the systemic effects of Smp43 on autophagy and assessing
of Smp43 and develop it into immunotherapeutic agents for its therapeutic potential and safety in whole organisms.
treating a range of conditions. 12 Evaluating Smp43 in models of conditions such as cancer,
neurodegeneration, and infections will provide insights into
2.4.3. Autophagy its potential as a therapeutic agent targeting diseases where
Autophagy is an essential cellular process involving modulating autophagy is beneficial. Ensuring selective
the degradation and recycling of cellular components, induction of autophagy in target cells without affecting
which helps maintain cellular homeostasis and manage normal cells is crucial for its safe therapeutic use. The various
stress. It may also inhibit the mTOR pathway, a major roles and effects of Smp43 are summarized in Table 1. 14
15

Volume 1 Issue 1 (2024) 75 doi: 10.36922/imo.4353